Neurosurgical oncology: advances in operative technologies and adjuncts
- PMID: 24969924
- DOI: 10.1007/s11060-014-1493-3
Neurosurgical oncology: advances in operative technologies and adjuncts
Abstract
Modern glioma surgery has evolved around the central tenet of safely maximizing resection. Recent surgical adjuncts have focused on increasing the maximum extent of resection while minimizing risk to functional brain. Technologies such as cortical and subcortical stimulation mapping, intraoperative magnetic resonance imaging, functional neuronavigation, navigable intraoperative ultrasound, neuroendoscopy, and fluorescence-guided resection have been developed to augment the identification of tumor while preserving brain anatomy and function. However, whether these technologies offer additional long-term benefits to glioma patients remains to be determined. Here we review advances over the past decade in operative technologies that have offered the most promising benefits for glioblastoma patients.
Similar articles
-
Optimizing glioblastoma resection: intraoperative mapping and beyond.CNS Oncol. 2014;3(5):359-66. doi: 10.2217/cns.14.36. CNS Oncol. 2014. PMID: 25363008 Free PMC article. Review.
-
The value of extent of resection of glioblastomas: clinical evidence and current approach.Curr Neurol Neurosci Rep. 2015;15(2):517. doi: 10.1007/s11910-014-0517-x. Curr Neurol Neurosci Rep. 2015. PMID: 25467408 Review.
-
Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.Neurosurgery. 2016 Apr;78(4):475-83. doi: 10.1227/NEU.0000000000001035. Neurosurgery. 2016. PMID: 26407129
-
Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme.J Pak Med Assoc. 2017 Oct;67(10):1630-1632. J Pak Med Assoc. 2017. PMID: 28955092 Review.
-
Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies.Chin J Cancer. 2014 Jan;33(1):8-15. doi: 10.5732/cjc.013.10219. Chin J Cancer. 2014. PMID: 24384236 Free PMC article. Review.
Cited by
-
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jul;9(4):10.1002/wnan.1439. doi: 10.1002/wnan.1439. Epub 2016 Nov 4. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 27813323 Free PMC article. Review.
-
On the use of fluorescein-based contrast agents as analogs to MRI-gadolinium agents for imaging brain tumors.Proc SPIE Int Soc Opt Eng. 2019 Feb;10862:108620V. doi: 10.1117/12.2510905. Epub 2019 Mar 7. Proc SPIE Int Soc Opt Eng. 2019. PMID: 31929673 Free PMC article.
-
Role of intraoperative ultrasound and MRI to aid grade of resection of pediatric low-grade gliomas: accumulated experience from 4 centers.Childs Nerv Syst. 2024 Oct;40(10):3165-3172. doi: 10.1007/s00381-024-06532-3. Epub 2024 Jul 16. Childs Nerv Syst. 2024. PMID: 39012356
-
Polymeric drug delivery for the treatment of glioblastoma.Neuro Oncol. 2015 Mar;17 Suppl 2(Suppl 2):ii9-ii23. doi: 10.1093/neuonc/nou360. Neuro Oncol. 2015. PMID: 25746091 Free PMC article. Review.
-
Rapid Label-Free Analysis of Brain Tumor Biopsies by Near Infrared Raman and Fluorescence Spectroscopy-A Study of 209 Patients.Front Oncol. 2019 Nov 5;9:1165. doi: 10.3389/fonc.2019.01165. eCollection 2019. Front Oncol. 2019. PMID: 31750251 Free PMC article.
References
-
- Pediatr Neurosurg. 2007;43(3):185-91 - PubMed
-
- J Neurol Surg A Cent Eur Neurosurg. 2012 Mar;73(2):73-8 - PubMed
-
- Neurosurgery. 2007 Nov;61(5):935-48; discussion 948-9 - PubMed
-
- Acta Neurochir (Wien). 2008 Oct;150(10):1033-41; discussion 1042 - PubMed
-
- J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):378-81 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous